LABCORP HOLDINGS INC. - Director's Dealing 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2023-02-07

Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-07	Common Stock	S	409	$243.01	Disposed	6687.4022	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-07	Restricted Stock Unit	$	A	1390	Acquired		Common Stock (1390)	Direct
2023-02-07	Non-qualified Stock Options	$247.24	A	4400	Acquired	2033-02-06	Common Stock (4400)	Direct

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3: The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.

F6: The option vests in three equal annual installments beginning on the date reflected in this column.